Documents

Ideas Discussions Technicals Forecast Seasonals

Mesoblast Limited documents

Explore the latest documents from Mesoblast Limited, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.

Description

Event date

Documents and forms

2025

H2 2025

Aug 28, 2025

Transcript

Slides

Annual report

Annual report10-K

International Society for Cell & Gene Therapy North America Virtual Town Hall

Mar 12, 2025

Slides

H1 2025

Feb 26, 2025

Transcript

Interim report

Slides

Q1 2025

Oct 29, 2024

Interim report

2024

FDA Announcement

Dec 19, 2024

Press release

AGM 2024

Nov 15, 2024

Slides

Q4 2024

Aug 28, 2024

Annual report10-K

Interim report

Slides

Corporate Presentation

Jun 3, 2024

Slides

Q2 2024

Feb 28, 2024

Interim report

Slides

Q1 2024

Oct 30, 2023

Interim report

2023

AGM 2023

Nov 28, 2023

Slides

Q4 2023

Aug 30, 2023

Annual report10-K

Slides

Annual report

FDA Announcement

Aug 4, 2023

Press release

Q3 2023

May 25, 2023

Slides

Interim report

Q2 2023

Feb 27, 2023

Interim report

Slides

Q1 2023

Nov 23, 2022

Slides

Interim report

2022

Q4 2022

Aug 31, 2022

Slides

Annual report10-K

Interim report

Q3 2022

Jun 1, 2022

Interim report

Slides

Q2 2022

Feb 25, 2022

Interim report

Slides

Q1 2022

Nov 24, 2021

Interim report

Slides

2021

AGM 2021

Nov 29, 2021

Slides

Q4 2021

Aug 30, 2021

Annual report10-K

Interim report

Slides

Q3 2021

Jun 2, 2021

Interim report

Slides